MicroStrategy purchases an additional 3,907 BTC for $177M invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
uniQure Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress mobilitytechzone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobilitytechzone.com Daily Mail and Mail on Sunday newspapers.
LogicBio Therapeutics Reports First Quarter Year 2021 Financial Results and Provides Business Update
- First patient for Phase 1/2 SUNRISE trial expected to be enrolled by mid-year 2021
- Business Development Deals signed with Daichi-Sankyo and CANbridge Pharmaceuticals
- New members recently added to Leadership Team
News provided by
Share this article
Share this article
LEXINGTON, Mass., May 10, 2021 /PRNewswire/ LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today reported financial results for the quarter ended March 31, 2021 and provided a business update.